SynBioBeta Speaker
Huafeng Xu
Founder and CEO
Atommap
May 2026, SynBioBeta
Speaker
Huafeng Xu, Ph. D., is the co-founder and CEO of Atommap, a New York-based biotech company transforming drug discovery through advanced computational methods. Atommap’s proprietary platform harnesses biomolecular dynamics to deliver therapeutic molecules that reprogram protein function. Since its founding in 2023, Atommap has partnered with 11 companies in their discovery projects and has on its own developed first-in-class molecules addressing a challenging oncological target. Huafeng previously served as Chief Technology Officer of Silicon Therapeutics, which Roivant acquired in 2021, then as CTO of Roivant Discovery before launching Atommap with his co-founders. Over his 25-year career as a chemist and computer scientist, he has developed the methods and software for molecular dynamics simulations and free energy calculations that are now widely used in the pharmaceutical industry, and he has pioneered the industrial application of computation-driven drug design. His publications have garnered over 10,000 citations. He earned his Bachelor of Science from Peking University and his M.S. and Ph. D. from Columbia University, and was a visiting postdoctoral scholar in UC San Francisco. In his spare time, Huafeng enjoys wine and solving math problems, sometimes simultaneously.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Conference Pass
1,995
USD
Save $1,000
Regular Rate
$2,995
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Meals & Refreshments
Post Event Video Access
Price increases in
08:07:12:11
Purchase Pass
Purchase Pass
Cyber Week Deal
Buy 1 Conference Pass, Get 1 Expo Pass Free
Previous Speakers Include
Join for the latest
SynBioBeta event updates.